{"DataElement":{"publicId":"4360181","version":"1","preferredName":"Positron Emission Tomography Computed Tomography Outcome Result Score","preferredDefinition":"A tumor response evaluation score that decribes the radiologist's impression of the PET/CT.","longName":"PET_CT_OTCM_RSLT_SCR","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"3366200","version":"1","preferredName":"PET CT Results","preferredDefinition":"A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. _A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered._The result of an action.","longName":"2729907v1.0:2224045v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"2729907","version":"1","preferredName":"Positron Emission Tomography Computed Tomography","preferredDefinition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.:A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. ","longName":"C17007:C17204","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Computed Tomography","conceptCode":"C17204","definition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46761A20-47B9-32EC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-18","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-02-18","modifiedBy":"ONEDATA","dateModified":"2008-02-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2224045","version":"1","preferredName":"Outcome","preferredDefinition":"A phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F061C-D115-4EFF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B774006F-54FE-23E5-E040-BB89AD432374","latestVersionIndicator":"Yes","beginDate":"2012-01-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-01-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"6/19/14 status changed to released. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4359031","version":"1","preferredName":"Positron Emission Tomography Computed Tomography Outcome Score","preferredDefinition":"Tumor response evaluation score based on  PET/CT.","longName":"PET_CT_OTCM_SCR","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Score 3: Likely inflammatory","valueDescription":"Likely Inflammatory Activity","ValueMeaning":{"publicId":"4359034","version":"1","preferredName":"Likely Inflammatory Activity","longName":"4359034","preferredDefinition":"A finding of metabolic activity at the primary or nodal sites that is greater than liver uptake, but can be attributed to inflammation activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Likely Inflammatory Activity by PET","conceptCode":"C116102","definition":"A finding of metabolic activity at the primary or nodal sites that is greater than liver uptake, but can be attributed to inflammation activity, as detected by FDG-PET.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC1F85B2-9DCC-AA07-E040-BB89AD434094","latestVersionIndicator":"Yes","beginDate":"2014-06-18","endDate":null,"createdBy":"PATELV","dateCreated":"2014-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC1F85B2-9DE5-AA07-E040-BB89AD434094","beginDate":"2014-06-18","endDate":null,"createdBy":"PATELV","dateCreated":"2014-06-18","modifiedBy":"ONEDATA","dateModified":"2014-06-18","deletedIndicator":"No"},{"value":"Score 4: Likely residual metabolic disease","valueDescription":"Likely Residual Metabolic Tumor Activity","ValueMeaning":{"publicId":"4359179","version":"1","preferredName":"Likely Residual Metabolic Tumor Activity","longName":"4359179","preferredDefinition":"A finding of focal metabolic activity at the primary or nodal sites that is greater than liver uptake.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Likely Residual Metabolic Tumor Activity by PET","conceptCode":"C116098","definition":"A finding of focal metabolic activity at the primary or nodal sites that is greater than liver uptake, as detected by FDG-PET.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC22462A-4648-D709-E040-BB89AD436748","latestVersionIndicator":"Yes","beginDate":"2014-06-18","endDate":null,"createdBy":"PATELV","dateCreated":"2014-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC22462A-4660-D709-E040-BB89AD436748","beginDate":"2014-06-18","endDate":null,"createdBy":"PATELV","dateCreated":"2014-06-18","modifiedBy":"ONEDATA","dateModified":"2014-06-18","deletedIndicator":"No"},{"value":"Score 2: Likely  complete metabolic response","valueDescription":"Likely Tumor Complete Metabolic Response","ValueMeaning":{"publicId":"4360180","version":"1","preferredName":"Likely Tumor Complete Metabolic Response","longName":"4360180","preferredDefinition":"A finding of diffuse metabolic activity at the primary tumor or nodal sites that is greater than background uptake but less than liver uptake.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Likely Tumor Complete Metabolic Response by PET","conceptCode":"C116096","definition":"A finding of diffuse metabolic activity at the primary tumor or nodal sites that is greater than background uptake but less than liver uptake, detected by PDG-PET.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC30AB4F-8623-EA1F-E040-BB89AD430C52","latestVersionIndicator":"Yes","beginDate":"2014-06-19","endDate":null,"createdBy":"PATELV","dateCreated":"2014-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC30AB4F-863C-EA1F-E040-BB89AD430C52","beginDate":"2014-06-19","endDate":null,"createdBy":"PATELV","dateCreated":"2014-06-19","modifiedBy":"ONEDATA","dateModified":"2014-06-19","deletedIndicator":"No"},{"value":"Score 1: Definite complete metabolic response","valueDescription":"Tumor Complete Metabolic Response","ValueMeaning":{"publicId":"4359035","version":"1","preferredName":"Tumor Complete Metabolic Response","longName":"4359035","preferredDefinition":"A finding of disappearance of metabolic tumor activity in target and non-target lesions, marked by a decrease in tumor standardized uptake value to the level of surrounding normal tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Complete Metabolic Response by PET","conceptCode":"C116095","definition":"A finding obtained using FDG-PET imaging demonstrating the disappearance of metabolic tumor activity in target and non-target lesions, marked by a decrease in tumor standardized uptake value to the level of surrounding normal tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC1F85B2-9DF1-AA07-E040-BB89AD434094","latestVersionIndicator":"Yes","beginDate":"2014-06-18","endDate":null,"createdBy":"PATELV","dateCreated":"2014-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC30AB4F-8687-EA1F-E040-BB89AD430C52","beginDate":"2014-06-18","endDate":null,"createdBy":"PATELV","dateCreated":"2014-06-19","modifiedBy":"ONEDATA","dateModified":"2014-06-19","deletedIndicator":"No"},{"value":"Score 5: Definite residual metabolic disease","valueDescription":"Definite Residual Metabolic Tumor Activity","ValueMeaning":{"publicId":"4359032","version":"1","preferredName":"Definite Residual Metabolic Tumor Activity","longName":"4359032","preferredDefinition":"A finding of strong focal metabolic activity at the primary or nodal sites that is greater than liver uptake.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Definite Residual Metabolic Tumor Activity by PET","conceptCode":"C116100","definition":"A finding of strong focal metabolic activity at the primary or nodal sites that is greater than liver uptake, as detected by FDG-PET.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC1F85B2-9D82-AA07-E040-BB89AD434094","latestVersionIndicator":"Yes","beginDate":"2014-06-18","endDate":null,"createdBy":"PATELV","dateCreated":"2014-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FDAFC685-CFDE-680C-E040-BB89AD436384","beginDate":"2014-06-18","endDate":null,"createdBy":"PATELV","dateCreated":"2014-07-08","modifiedBy":"ONEDATA","dateModified":"2014-07-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2842596","version":"1","preferredName":"Outcome of Therapy","preferredDefinition":"The result of therapy for a given disease or condition in a patient or group of patients.","longName":"C18919 ","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63D982FA-DFBF-58C7-E040-BB89AD433E84","latestVersionIndicator":"Yes","beginDate":"2009-02-26","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-02-26","modifiedBy":"CURTIST","dateModified":"2009-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2193207","version":"1","preferredName":"Score","preferredDefinition":"A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"EACFDBFA-EFD4-25E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-12-09","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NRG CRF:NRG Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC1F85B2-9D6C-AA07-E040-BB89AD434094","latestVersionIndicator":"Yes","beginDate":"2014-06-18","endDate":null,"createdBy":"PATELV","dateCreated":"2014-06-18","modifiedBy":"PATELV","dateModified":"2014-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"PET_CT_OTCM_RSLT_SCR","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Overall tumor response evalua","type":"Preferred Question Text","description":"Overall tumor response evaluation score","url":null,"context":"NRG"}],"origin":"NRG CRF:NRG Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC30AB4F-8646-EA1F-E040-BB89AD430C52","latestVersionIndicator":"Yes","beginDate":"2014-06-19","endDate":null,"createdBy":"PATELV","dateCreated":"2014-06-19","modifiedBy":"FORMBUILDER","dateModified":"2014-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}